Short Interest Worth Mentioning: It Seems Cynosure Incorporated (NASDAQ:CYNO) Will Go Down. Just Reported More Shorted Shares

December 1, 2016 - By Vivian Park   ·   0 Comments

Short Interest Worth Mentioning: It Seems Cynosure Incorporated (NASDAQ:CYNO) Will Go Down. Just Reported More Shorted Shares

The stock of Cynosure Incorporated (NASDAQ:CYNO) registered an increase of 23.26% in short interest. CYNO’s total short interest was 2.00M shares in December as published by FINRA. Its up 23.26% from 1.62 million shares, reported previously. With 580,900 shares average volume, it will take short sellers 3 days to cover their CYNO’s short positions. The stock decreased 1.20% or $0.55 during the last trading session, hitting $45.35. Cynosure, Inc. (NASDAQ:CYNO) has declined 6.94% since April 28, 2016 and is downtrending. It has underperformed by 12.86% the S&P500.

Cynosure Inc. develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The company has a market cap of $1.10 billion. The Firm operates through aesthetic treatment services and products segment. It has a 51.51 P/E ratio. It markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology.

Insitutional Activity: The institutional sentiment decreased to 1.63 in 2016 Q2. Its down 0.42, from 2.05 in 2016Q1. The ratio dived, as 13 funds sold all Cynosure, Inc. shares owned while 43 reduced positions. 43 funds bought stakes while 72 increased positions. They now own 23.16 million shares or 3.96% more from 22.27 million shares in 2016Q1.
Pinebridge Invs Limited Partnership reported 2,983 shares or 0.01% of all its holdings. Geode Cap Mgmt Ltd Limited Liability Company last reported 0% of its portfolio in the stock. Turner Investments Lp, a Pennsylvania-based fund reported 20,000 shares. Secor Capital Advsr Limited Partnership accumulated 76,276 shares or 0.47% of the stock. Olstein Management Lp accumulated 0.2% or 30,375 shares. Pura Vida Invests Limited Co has 1.24% invested in the company for 60,000 shares. The New Jersey-based New Jersey Better Educational Savings Trust has invested 0.52% in Cynosure, Inc. (NASDAQ:CYNO). Hood River Mgmt Ltd Limited Liability Company owns 179,189 shares or 1.17% of their US portfolio. Gotham Asset Ltd Liability holds 0.02% of its portfolio in Cynosure, Inc. (NASDAQ:CYNO) for 30,088 shares. Principal Financial Grp Inc holds 0.03% of its portfolio in Cynosure, Inc. (NASDAQ:CYNO) for 391,455 shares. Blackrock Fund last reported 1.61M shares in the company. Teachers Retirement Of The State Of Kentucky holds 0.02% or 29,386 shares in its portfolio. Eagle Boston Inv Management last reported 92,949 shares in the company. Tower Rech Capital Limited Liability (Trc) has 972 shares for 0% of their US portfolio. Jpmorgan Chase & accumulated 0% or 165,176 shares.

Insider Transactions: Since August 11, 2016, the stock had 0 buys, and 9 selling transactions for $3.88 million net activity. $311,236 worth of Cynosure, Inc. (NASDAQ:CYNO) was sold by BAKER TIMOTHY W. Davin Michael R sold $224,540 worth of stock or 4,222 shares. Delaney Douglas J sold $108,595 worth of stock. Shares for $1.08M were sold by BAREFOOT BRIAN M..

Cynosure, Inc. (NASDAQ:CYNO) Ratings Coverage

Out of 3 analysts covering Cynosure Inc (NASDAQ:CYNO), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $52 is the highest target while $44 is the lowest. The $51 average target is 12.46% above today’s ($45.35) stock price. Cynosure Inc has been the topic of 6 analyst reports since August 13, 2015 according to StockzIntelligence Inc. The stock of Cynosure, Inc. (NASDAQ:CYNO) has “Buy” rating given on Thursday, November 3 by Aegis Capital. Zacks upgraded the stock to “Sell” rating in Tuesday, August 18 report. The rating was upgraded by Stifel Nicolaus to “Buy” on Monday, September 14. The firm earned “Buy” rating on Tuesday, December 22 by Maxim Group. The firm has “Buy” rating given on Tuesday, January 5 by Stifel Nicolaus. The rating was initiated by Stifel Nicolaus with “Hold” on Thursday, August 13.

CYNO Company Profile

Cynosure Inc. (Cynosure), incorporated on July 10, 1991, develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. The Firm operates through aesthetic treatment services and products segment. The Firm also markets radiofrequency (RF) energy sourced medical devices for precision surgical applications, such as facial plastic and general surgery; gynecology; ear, nose and throat procedures; ophthalmology; oral and maxillofacial surgery; podiatry, and proctology. The Company’s product portfolio utilizes a range of energy sources, including Alexandrite, diode, neodymium-doped yttrium aluminum garnet (Nd: YAG), pulse dye, Q-switched lasers, intense pulsed light and RF technology. It offers single energy source systems, as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. The Company’s products include Elite, SmartLipo, Cellulaze, Cynergy, Accolade, MedLite C6, PicoSure, Icon aesthetic system, Vectus, SculpSure hyperthermic laser treatment and MonaLisa Touch laser.

Another recent and important Cynosure, Inc. (NASDAQ:CYNO) news was published by Prnewswire.com which published an article titled: “Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent …” on October 25, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Vivian Park


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>